A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis

Status unconfirmed · Phase 1/Phase 2

Conditions studied: Rheumatoid Arthritis, Osteoarthritis

In brief

The purpose of the study is to evaluate the safety and efficacy of Cura-100 in treating rheumatoid arthritis and osteoarthritis.

Key facts

Study ID

NCT00455208

Run by

Cura Biotech LLC

People needed

20

Starts

2007-05-01

Expected to finish

2008-12-01

Last updated by the study team

2009-02-19

Who can join

Age: 20 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Having a diagnosis of rheumatoid arthritis and osteoarthritis at active stage
• Able and willing to comply with study visits and procedures specified in this protocol for at least six months period
• Able to understand and willing to sign and date the written informed consent form prior to admission of the study
• Able and willing to provide adequate information for locator purposes
• Able and willing to provide self evaluation information and diagnostic report of arthritis as required for efficacy evaluation

You may not qualify if…

• Pregnant women
• Over-weighted
• Hypertension, or diabetes, or a history of cardiovascular disease or kidney disease, or serious skin allergy or other concurrent clinically significant illness or medical condition (other than arthritis) which, in the viewpoint of the study doctor, may put the subject at a possible risk for participation
• Patients used biologic modifier therapy or currently taking immunosuppressive agents might be excluded
• Unable to spend 3 hours for treatment at the study center

Where it is running

• Cura Biotech LLC — Sunnyvale, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.